The dialogue surrounding rescheduling cannabis from its designation as Schedule I drug as a part of the Controlled Substances Act of 1970 is gaining traction. The potential of rescheduling to Schedule III could open the floodgates for cannabis research, Dr. Gruber says. Diti Kohli from the Boston Globe covers the story here.
top of page
bottom of page